Skip to main content
logo
NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
2.030
-0.120 (-5.58%)
At close: Aug 21, 2026, 4:00 PM EDT
2.310
+0.280 (13.79%)
After-hours: Aug 21, 2026, 7:39 PM EDT

NMTC Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
12.4712.13.453.412.120.24
Revenue Growth
88.09%250.35%1.33%60.73%772.60%-87.39%
Gross Profit
2.873.16-3.99-5.03-3.05-3.96
Operating Income
-7.9-4.23-11.89-11.96-10.03-10.22
Net Income
-7.45-3.61-12.32-11.86-10-9.95
Earnings Per Share
-0.95-0.54-2.76-3.93-3.75-5.58
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Cash & Investments
2.056.571.465.3211.146.9
Total Debt
0.180.270.260.180.20.32
Net Cash (Debt)
1.876.31.25.1410.946.59
Net Cash Growth
-75.82%425.35%-76.65%-53.03%66.09%150.06%
Net Cash Per Share
0.220.940.271.704.103.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Operating Cash Flow
-7.05-2.84-11.01-12.89-7.52-8.6
Capital Expenditures
-0.11-0.08-0.12-0.38-0.28-0.07
Free Cash Flow
-7.16-2.92-11.13-13.27-7.79-8.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Gross Margin
23.00%26.11%-115.42%-147.58%-143.93%-
Operating Margin
-63.36%-34.94%-344.26%-350.84%-473.14%-4205.75%
Pretax Margin
-59.71%-29.80%-356.74%-348.03%-471.67%-4094.60%
Profit Margin
-59.71%-29.80%-356.74%-348.03%-471.67%-4094.60%
FCF Margin
-57.44%-24.13%-322.39%-389.45%-367.67%-3568.48%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
1.483.678.836.2512.92195.11